A street drug-testing pilot scheme in Somerset has shown that pharmacists could have a massive impact on reducing illicit drug use, but this work will go no further than the county line if funding is not found.
The warning lights are flashing, but 2019 could mark a turning point.
The pharmacy regulator must be more transparent about how it conducts fitness-to-practise investigations if trust in its ability to do a fair job is to be maintained.
Pharmacists supporting patients to appropriately treat sudden, short bouts of pain through self-care will put patients at the centre of their treatment.
It is understandable that pharmacists are reluctant to buy expensive equipment and change their workflows to comply with the Falsified Medicines Directive when the legislation may no longer apply after Brexit.
In January 2019, Boots announced that it was changing the way it dispenses medicines to care homes — from multicompartment compliance aids to original packs.
Much can be done to improve the quality of life for patients presenting to their community pharmacy with joint pain.
Cuts to preregistration placement funding threaten to undo all the progress that has been made across pharmacy in recent years.
Although the ‘NHS Long-Term Plan’ outlines some potential new roles for pharmacists, the lack of detail on plans for community pharmacy are cause for concern.
Please answer this short survey to provide us with your feedback to help us shape the future of RPS MyCPD.
Pharmacy should take Brexit leadSubscription
As discussions continue over the relationship the UK will have with the EU, pharmacy bodies must do what they can to protect the interests of patients, whichever form of Brexit emerges.
Well-run pharmacies have nothing to fear as the General Pharmaceutical Council develops a tougher stance on inspections. But the regulator must prove that changes to its regime will drive continuous improvement.
BAME pharmacist pay: a hidden injusticeSubscription
As a survey suggests that Black, Asian and minority ethnic pharmacists are paid on average 16% less than their white counterparts, The Salvadore asks whether pharmacy employers should be compelled to publish ethnicity pay gap figures alongside gender pay gap statistics.